Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2008 1
2009 6
2015 1
2020 5
2021 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Ranibizumab for diabetic retinopathy.
Rodriguez-Fontal M, Alfaro V, Kerrison JB, Jablon EP. Rodriguez-Fontal M, et al. Among authors: jablon ep. Curr Diabetes Rev. 2009 Feb;5(1):47-51. doi: 10.2174/157339909787314239. Curr Diabetes Rev. 2009. PMID: 19199898 Review.
Diabetic retinopathy and angiogenesis.
Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP. Crawford TN, et al. Among authors: jablon ep. Curr Diabetes Rev. 2009 Feb;5(1):8-13. doi: 10.2174/157339909787314149. Curr Diabetes Rev. 2009. PMID: 19199892 Review.
Anti-macular degeneration agents.
Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV 3rd. Rothen M, et al. Among authors: jablon e. Ophthalmol Clin North Am. 2005 Dec;18(4):561-7. doi: 10.1016/j.ohc.2005.07.009. Ophthalmol Clin North Am. 2005. PMID: 16314219 Review.
Metabolic control and diabetic retinopathy.
Rodriguez-Fontal M, Kerrison JB, Alfaro DV, Jablon EP. Rodriguez-Fontal M, et al. Among authors: jablon ep. Curr Diabetes Rev. 2009 Feb;5(1):3-7. doi: 10.2174/157339909787314176. Curr Diabetes Rev. 2009. PMID: 19199891 Review.
Fishing-related ocular trauma.
Alfaro DV 3rd, Jablon EP, Rodriguez Fontal M, Villalba SJ, Morris RE, Grossman M, Roig-Melo E. Alfaro DV 3rd, et al. Among authors: jablon ep. Am J Ophthalmol. 2005 Mar;139(3):488-92. doi: 10.1016/j.ajo.2004.10.011. Am J Ophthalmol. 2005. PMID: 15767058
Chatbot-based serious games: A useful tool for training medical students? A randomized controlled trial.
Al Kahf S, Roux B, Clerc S, Bassehila M, Lecomte A, Moncomble E, Alabadan E, de Montmolin N, Jablon E, François E, Friedlander G, Badoual C, Meyer G, Roche N, Martin C, Planquette B. Al Kahf S, et al. Among authors: jablon e. PLoS One. 2023 Mar 13;18(3):e0278673. doi: 10.1371/journal.pone.0278673. eCollection 2023. PLoS One. 2023. PMID: 36913346 Free PMC article. Clinical Trial.
20 results